About Focus Pipeline Investors Contact Investor Relations Investor Overview SEC Filings Press Releases Corporate Governance Events & Presentations Contact Investor Relations Stock Quote Investor Presentation September 2021 Click to Download Click to Submit Incident Report About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Contact Us For questions regarding investor relations, please contact Stephanie Prince at: sprince@pcgadvisory.com. Name Email Leave us a message... Submit About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Our Focus Overview Congenital Ichthyosis Tuberous Sclerosis Complex Localized Scleroderma Localized Scleroderma Localized Scleroderma is a rare autoimmune connective tissue disorder (CTD) that leads to inflammation and thickening of the skin. About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact About Timber Pharmaceuticals About Us Management Team Board of Directors Partnerships Board of Directors Zachary Rome CHIEF OPERATING OFFICER Zach is a biopharmaceutical inventor, entrepreneur and executive. He is a Co-Founder of Timber and has served as the Company’s President since its inception. Zach is also a Partner at TardiMed Sciences, a life sciences company creation firm. At TardiMed, Zach has helped to form several life sciences companies that span multiple therapeutic areas and stages of development. Read more About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Press Releases Investor Relations Investor Overview SEC Filings Press Releases Corporate Governance Events & Presentations Contact Investor Relations Stock Quote About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Investor Relations Corporate Governance Audit Committee Charter Code of Conduct Compensation Committee Chart Nominating and Corporate Governance Charter Related Person Transaction Policy Investor Overview SEC Filings Press Releases Corporate Governance Events & Presentations Contact Investor Relations Stock Quote About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Our Focus Overview Congenital Ichthyosis Tuberous Sclerosis Complex Localized Scleroderma There are many unmet needs in medical dermatology, especially in rare dermatologic diseases that may not have any approved therapies. In many of these cases, oral therapies that are often used off-label have demonstrated efficacy but may be associated with serious systemic toxicity, which then limits their viability as a treatment option. Recent research has demonstrated that novel topical formulations of these drugs may represent safer treatment options that can lead to important clinically meaningful outcomes in many rare dermatologic diseases. About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC